Literature DB >> 25512634

Molecular pathways: microRNAs, cancer cells, and microenvironment.

Ioana Berindan-Neagoe1, George A Calin2.   

Abstract

One of the most unexpected discoveries in molecular oncology over the last decade is the interplay between abnormalities in protein-coding genes and short noncoding microRNAs (miRNA) that are causally involved in cancer initiation, progression, and dissemination. This phenomenon was initially defined in malignant cells; however, in recent years, more data have accumulated describing the active participation of miRNAs produced by microenvironment cells. As hormones, miRNAs can be released by a donor cell in various forms of vesicles or as "free" molecules secreted by active mechanisms. These miRNAs spread as signaling molecules that are uptaken either as exosomes or as "free" RNAs, by cells located in other parts of the organism. Here, we discuss the communication between cancer cells and the microenvironment through miRNAs. We further expand this in a more translational context and present miRNAs as predictors of treatment response, as crucial agents in targeted therapeutics, and as significant molecules to target. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25512634      PMCID: PMC4461223          DOI: 10.1158/1078-0432.CCR-13-2500

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  54 in total

Review 1.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

Review 2.  Illuminating the silence: understanding the structure and function of small RNAs.

Authors:  Tariq M Rana
Journal:  Nat Rev Mol Cell Biol       Date:  2007-01       Impact factor: 94.444

3.  Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.

Authors:  Alessandra Ferrajoli; Tait D Shanafelt; Cristina Ivan; Masayoshi Shimizu; Kari G Rabe; Nazila Nouraee; Mariko Ikuo; Asish K Ghosh; Susan Lerner; Laura Z Rassenti; Lianchun Xiao; Jianhua Hu; James M Reuben; Steliana Calin; M James You; John T Manning; William G Wierda; Zeev Estrov; Susan O'Brien; Thomas J Kipps; Michael J Keating; Neil E Kay; George A Calin
Journal:  Blood       Date:  2013-07-02       Impact factor: 22.113

Review 4.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development.

Authors:  Hui Ling; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

5.  Micromanaging hepatitis C virus.

Authors:  Judy Lieberman; Peter Sarnow
Journal:  N Engl J Med       Date:  2013-03-27       Impact factor: 91.245

6.  Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.

Authors:  Muller Fabbri; Arianna Bottoni; Masayoshi Shimizu; Riccardo Spizzo; Milena S Nicoloso; Simona Rossi; Elisa Barbarotto; Amelia Cimmino; Brett Adair; Sylwia E Wojcik; Nicola Valeri; Federica Calore; Deepa Sampath; Francesca Fanini; Ivan Vannini; Gerardo Musuraca; Marie Dell'Aquila; Hansjuerg Alder; Ramana V Davuluri; Laura Z Rassenti; Massimo Negrini; Tatsuya Nakamura; Dino Amadori; Neil E Kay; Kanti R Rai; Michael J Keating; Thomas J Kipps; George A Calin; Carlo M Croce
Journal:  JAMA       Date:  2011-01-05       Impact factor: 56.272

7.  The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts.

Authors:  Olga Aprelikova; Xiang Yu; John Palla; Bih-Rong Wei; Simone John; Ming Yi; Robert Stephens; R Mark Simpson; John I Risinger; Amir Jazaeri; John Niederhuber
Journal:  Cell Cycle       Date:  2010-11-17       Impact factor: 4.534

8.  Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy.

Authors:  Hai-Liang Zhang; Li-Feng Yang; Yao Zhu; Xu-Dong Yao; Shi-Lin Zhang; Bo Dai; Yi-Ping Zhu; Yi-Jun Shen; Guo-Hai Shi; Ding-Wei Ye
Journal:  Prostate       Date:  2010-09-14       Impact factor: 4.104

9.  Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells.

Authors:  Hiroko Tadokoro; Tomohiro Umezu; Kazuma Ohyashiki; Toshihiko Hirano; Junko H Ohyashiki
Journal:  J Biol Chem       Date:  2013-10-16       Impact factor: 5.157

10.  Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma.

Authors:  Nazila Nouraee; Katrien Van Roosbroeck; Mohammad Vasei; Shahriar Semnani; Nader Mansour Samaei; Farshad Naghshvar; Abbas Ali Omidi; George A Calin; Seyed Javad Mowla
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

View more
  44 in total

1.  A tumor-suppressive microRNA, miRNA-485-5p, inhibits glioma cell proliferation and invasion by down-regulating TPD52L2.

Authors:  Jin Yu; Shi-Wen Wu; Wei-Ping Wu
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 2.  Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.

Authors:  Fu Peng; Liang Xiong; Hailin Tang; Cheng Peng; Jianping Chen
Journal:  Tumour Biol       Date:  2016-09-19

Review 3.  Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention.

Authors:  Nicholas H Farina; Areg Zingiryan; Michael A Vrolijk; Scott D Perrapato; Steven Ades; Gary S Stein; Jane B Lian; Christopher C Landry
Journal:  J Cell Physiol       Date:  2018-04-16       Impact factor: 6.384

4.  Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study.

Authors:  Eric J Duell; Leila Lujan-Barroso; Núria Sala; Samantha Deitz McElyea; Kim Overvad; Anne Tjonneland; Anja Olsen; Elisabete Weiderpass; Lill-Tove Busund; Line Moi; David Muller; Paolo Vineis; Dagfinn Aune; Giuseppe Matullo; Alessio Naccarati; Salvatore Panico; Giovanna Tagliabue; Rosario Tumino; Domenico Palli; Rudolf Kaaks; Verena A Katzke; Heiner Boeing; H B As Bueno-de-Mesquita; Petra H Peeters; Antonia Trichopoulou; Pagona Lagiou; Anastasia Kotanidou; Ruth C Travis; Nick Wareham; Kay-Tee Khaw; Jose Ramon Quiros; Miguel Rodríguez-Barranco; Miren Dorronsoro; María-Dolores Chirlaque; Eva Ardanaz; Gianluca Severi; Marie-Christine Boutron-Ruault; Vinciane Rebours; Paul Brennan; Marc Gunter; Ghislaine Scelo; Greg Cote; Stuart Sherman; Murray Korc
Journal:  Int J Cancer       Date:  2017-06-12       Impact factor: 7.396

5.  Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.

Authors:  Yuuki Iida; Aaron Ciechanover; Diego M Marzese; Keisuke Hata; Matias Bustos; Shigeshi Ono; Jinhua Wang; Matthew P Salomon; Kevin Tran; Stella Lam; Sandy Hsu; Nellie Nelson; Yelena Kravtsova-Ivantsiv; Gordon B Mills; Michael A Davies; Dave S B Hoon
Journal:  Clin Cancer Res       Date:  2017-04-07       Impact factor: 12.531

Review 6.  Overview upon miR-21 in lung cancer: focus on NSCLC.

Authors:  Cecilia Bica-Pop; Roxana Cojocneanu-Petric; Lorand Magdo; Lajos Raduly; Diana Gulei; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

7.  Overexpression of adenosine deaminase acting on RNA 1 in chordoma tissues is associated with chordoma pathogenesis by reducing miR‑125a and miR‑10a expression.

Authors:  Lei Kuang; Guohua Lv; Bing Wang; Lei Li; Yuliang Dai; Yawei Li
Journal:  Mol Med Rep       Date:  2015-02-12       Impact factor: 2.952

8.  Transcriptomic Profiling Identifies an Exosomal microRNA Signature for Predicting Recurrence Following Surgery in Patients with Pancreatic Ductal Adenocarcinoma.

Authors:  Satoshi Nishiwada; Ya Cui; Masayuki Sho; Eunsung Jun; Takahiro Akahori; Kota Nakamura; Fuminori Sonohara; Suguru Yamada; Tsutomu Fujii; In Woong Han; Susan Tsai; Yasuhiro Kodera; Joon Oh Park; Daniel Von Hoff; Song Cheol Kim; Wei Li; Ajay Goel
Journal:  Ann Surg       Date:  2021-06-16       Impact factor: 12.969

9.  FER Regulated by miR-206 Promotes Hepatocellular Carcinoma Progression via NF-κB Signaling.

Authors:  Wenzhou Ding; Ye Fan; Wenbo Jia; Xiongxiong Pan; Guoyong Han; Yao Zhang; Zhiqiang Chen; Yiwei Lu; Jinyi Wang; Jindao Wu; Xuehao Wang
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

Review 10.  Salivary exosomal microRNAs as biomarkers for head and neck cancer detection-a literature review.

Authors:  Cosmin Ioan Faur; Horatiu Rotaru; Ciprian Osan; Ancuta Jurj; Rares Calin Roman; Madalina Moldovan; Magdalena Chirila; Mihaela Hedesiu
Journal:  Maxillofac Plast Reconstr Surg       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.